ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,372Medicare Part D Prescriptions Filled, Including Refills

Rank: 23 out of 1383

$1.14M Total Retail Price of All Prescriptions

Rank: 39 out of 1383

639 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
85% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 639 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

36% of this provider’s 639 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 23,118 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

43 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
FUROSEMIDE 1,460 1,313 1 7
HYDROCODONE-ACETAMINOPHEN 1,390 1,149 S3 2 1
WARFARIN SODIUM 1,352 1,313 3 13
POTASSIUM CHLORIDE 827 784 4 12
SIMVASTATIN 712 576 5 2
LEVOTHYROXINE SODIUM 657 573 6 4
OMEPRAZOLE 618 524 7 5
LISINOPRIL 602 492 8 3
METFORMIN HCL 548 477 9 8
SERTRALINE HCL 512 392 10 21
GABAPENTIN 509 411 11 11
METOPROLOL TARTRATE 473 428 12 9
AMLODIPINE BESYLATE 472 424 13 6
CITALOPRAM HBR 395 355 14 15
LANTUS 345 278 15 50
PANTOPRAZOLE SODIUM 312 282 16 32
MIRTAZAPINE 262 238 17 51
DONEPEZIL HCL 259 244 18 35
TRAZODONE HCL 252 206 19 36
CARVEDILOL 229 190 20 24
HYDROCHLOROTHIAZIDE 222 207 21 10
CYCLOBENZAPRINE HCL 209 146 R 22 69
ATENOLOL 207 175 23 16
NAMENDA 205 197 24 49
QUETIAPINE FUMARATE 204 168 25 70
ZOLPIDEM TARTRATE 203 127 26 17
AZITHROMYCIN 199 153 27 41
FAMOTIDINE 194 192 28 61
KLOR-CON M20 187 150 29 100
METOPROLOL SUCCINATE 185 161 30 29
PREDNISONE 167 131 31 40
IPRATROPIUM-ALBUTEROL 166 164 32 138
FENTANYL 161 125 S2 33 92
TRAMADOL HCL 155 128 34 25
ALLOPURINOL 154 137 35 33
GLYBURIDE 151 130 R 36 46
CIPROFLOXACIN HCL 149 134 37 54
CLONIDINE HCL 148 141 38 44
OXYBUTYNIN CHLORIDE 146 106 39 115
PRAVASTATIN SODIUM 144 138 40 14
SULFAMETHOXAZOLE-TRIMETHOPRIM 143 120 41 89
PROMETHAZINE HCL 142 84 R 42 56
CYMBALTA 141 105 43 53
POLYETHYLENE GLYCOL 3350 140 130 44 64
CLOPIDOGREL 140 126 44 28
BACLOFEN 137 116 46 118
ATORVASTATIN CALCIUM 136 116 47 18
OXYBUTYNIN CHLORIDE ER 132 118 48 173
SPIRONOLACTONE 132 109 48 67
RISPERIDONE 131 118 50 71
MELOXICAM 130 111 51 20
TRIAMTERENE-HCTZ 117 102 52 48
NYSTATIN 116 97 53 132
OXYCODONE-ACETAMINOPHEN 116 55 S2 53 107
FLUTICASONE PROPIONATE 116 78 53 39
GLIPIZIDE 113 101 56 98
KLOR-CON 10 113 110 56 74
AMOX TR-POTASSIUM CLAVULANATE 112 96 58 106
MORPHINE SULFATE ER 112 74 S2 58 77
ALENDRONATE SODIUM 111 94 60 37
IBUPROFEN 110 74 61 91
PLAVIX 105 98 62 43
ISOSORBIDE DINITRATE 105 100 62 216
HYDRALAZINE HCL 105 82 62 86
DIVALPROEX SODIUM 104 91 65 78
LOVASTATIN 101 78 66 22
TAMSULOSIN HCL 100 96 67 30
LAMOTRIGINE 100 75 67 210
ALBUTEROL SULFATE 99 94 69 124
ADVAIR DISKUS 98 81 70 63
LEVOFLOXACIN 98 87 70 88
METOLAZONE 97 97 72 221
CEPHALEXIN 96 72 73 87
NEXIUM 95 78 74 26
FLOVENT HFA 91 88 75 259
ESCITALOPRAM OXALATE 91 82 75 99
RANITIDINE HCL 87 57 77 19
OXYCODONE HCL-ACETAMINOPHEN 86 53 S2 78 81
LEVETIRACETAM 86 49 78 134
VENTOLIN HFA 85 33 80 93
ROPINIROLE HCL 83 29 81 79
DIGOXIN 83 71 81 59
RAMIPRIL 83 73 81 80
CARBIDOPA-LEVODOPA 82 65 84 108
HUMALOG 81 26 85 176
NOVOLOG MIX 70-30 80 80 86 273
EXELON 80 66 86 117
ISOSORBIDE MONONITRATE ER 79 79 88 66
MECLIZINE HCL 78 67 89 113
LYRICA 77 39 90 72
DILTIAZEM ER 77 77 90 110
NIFEDIPINE ER 76 75 92 126
LOSARTAN POTASSIUM 75 74 93 23
OLANZAPINE 74 74 94 164
FLUOXETINE HCL 73 45 95 52
OXYCODONE HCL 72 69 S2 96 62
COLCRYS 72 64 96 214
HYDROXYZINE HCL 72 58 R 96 151
GLIMEPIRIDE 70 53 99 31
CEFUROXIME 69 66 100 164
VESICARE 68 28 101 182
AMITRIPTYLINE HCL 67 50 R 102 57
AMOXICILLIN 67 50 102 119
SINGULAIR 66 52 104 82
BUMETANIDE 66 66 104 122
PROAIR HFA 65 57 106 42
AMIODARONE HCL 64 62 107 188
DIOVAN 64 64 107 58
NITROFURANTOIN MONO-MACRO 64 56 107 193
RIVASTIGMINE 60 60 110 239
NOVOLOG 59 56 111 139
NYSTATIN-TRIAMCINOLONE 58 43 112 275
TRIAMCINOLONE ACETONIDE 58 49 112 159
SEROQUEL 57 50 114 130
NASONEX 57 44 114 234
KETOCONAZOLE 56 47 116 271
DOXYCYCLINE HYCLATE 56 40 116 94
FLUCONAZOLE 54 39 118 136
NYAMYC 53 48 119 318
AGGRENOX 52 52 120 191
VENLAFAXINE HCL ER 52 47 120 102
FINASTERIDE 51 51 122 121
FENOFIBRATE 51 44 122 65
COMBIVENT 51 28 122 116
PAROXETINE HCL 50 47 125 55
IPRATROPIUM BROMIDE 50 44 125 174
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 22, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.